Cargando…

NUCLEAR DEFECTIVE IL-33 DRIVES AN ANTI-TUMORIGENIC MICROENVIRONMENT IN GLIOBLASTOMA

Despite a sophisticated treatment regimen, including surgery, chemotherapy, and radiotherapy, survival outcomes for glioblastoma remain at a dismal 14.6 months. Multi-omics profiling have established that myeloid phagocytes drive glioma progression and contribute to therapeutic resistance. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menon, Shyam V, Lun, Xueqing, Zhang, Jianbo, Ahn, Bo Young, Yu, Henry, Poole, Alisha, Dang, Ngoc Ha, Osz, Katalin, Chan, Jennifer, Robbins, Stephen M, Senger, Donna L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337527/ http://dx.doi.org/10.1093/noajnl/vdad071.038

Ejemplares similares

EXPLORING THE ROLE OF GAT1 AND GABA IN TEMOZOLOMIDE TREATED GLIOMA
por: Poole, Alisha, et al.
Publicado: (2023)

Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
por: De Boeck, Astrid, et al.
Publicado: (2020)

To promote or inhibit glioma progression, that is the question for IL-33
por: Robbins, Stephen M., et al.
Publicado: (2020)

Snail depletes the tumorigenic potential of glioblastoma
por: Savary, K, et al.
Publicado: (2013)

Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis
por: Chen, Lijie, et al.
Publicado: (2020)

Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight
por: Andreone, Sara, et al.
Publicado: (2020)

Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma
por: Fiorilla, Irene, et al.
Publicado: (2023)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

Sprouty2 enhances the tumorigenic potential of glioblastoma cells
por: Park, Jong-Whi, et al.
Publicado: (2018)

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme
por: Becker, Yvonne, et al.
Publicado: (2019)

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
por: Beug, Shawn T., et al.
Publicado: (2017)

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells
por: Lamballe, Fabienne, et al.
Publicado: (2016)

Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
por: Zhang, Fengyu, et al.
Publicado: (2020)

Elucidating the Anti-Tumorigenic Efficacy of Oltipraz, a Dithiolethione, in Glioblastoma
por: Kapoor-Narula, Upasana, et al.
Publicado: (2022)

Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
por: Beug, Shawn T., et al.
Publicado: (2018)

macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma
por: Nikolic, Ana, et al.
Publicado: (2023)

Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness
por: Bogeas, Alexandra, et al.
Publicado: (2017)

The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
por: Fournié, Jean-Jacques, et al.
Publicado: (2018)

Interleukin-33/ Suppression of Tumorigenicity 2 in Renal Fibrosis: Emerging Roles in Prognosis and Treatment
por: Tan, Xiao-Yang, et al.
Publicado: (2022)

Copper(II) Complexes of Amino Acids and Peptides Containing Chelating bis(imidazolyl) Residues
por: Sóvágó, lmre, et al.
Publicado: (2003)

Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
por: Hasan, Tanwir, et al.
Publicado: (2019)

Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice
por: Bi, Pengpeng, et al.
Publicado: (2016)

Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells
por: Tenan, Mirna, et al.
Publicado: (2000)

Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma
por: Tunici, Patrizia, et al.
Publicado: (2004)

REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
por: Conti, Luciano, et al.
Publicado: (2012)

DGKζ Plays Crucial Roles in the Proliferation and Tumorigenicity of Human glioblastoma
por: Gu, Xuefeng, et al.
Publicado: (2019)

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells
por: Grinshtein, Natalie, et al.
Publicado: (2016)

Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential
por: Huang, Fang, et al.
Publicado: (2022)

Terminal differentiation and anti-tumorigenic effects of prolactin in breast cancer
por: Ali, Suhad, et al.
Publicado: (2022)

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
por: Golebiewska, Anna, et al.
Publicado: (2013)

Correction: REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
Publicado: (2015)

Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma
por: Mikheev, Andrei M., et al.
Publicado: (2018)

Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
por: Fujikawa, Akihiro, et al.
Publicado: (2017)

Phospholipase D1 inhibition sensitizes glioblastoma to temozolomide and suppresses its tumorigenicity
por: Kang, Dong Woo, et al.
Publicado: (2020)

Role of Lamin A/C as Candidate Biomarker of Aggressiveness and Tumorigenicity in Glioblastoma Multiforme
por: Gatti, Giuliana, et al.
Publicado: (2021)

GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
por: Watson, Dionysios C., et al.
Publicado: (2023)

Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics
por: Poli, Vittoria, et al.
Publicado: (2018)

Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer
por: He, Ningning, et al.
Publicado: (2016)

The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression
por: Gilad, Nechama, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cnm1e66as8rvq2malptf44sel4